BRPI0716929A2 - tratamento de esclerose méltipla com campath-1h - Google Patents

tratamento de esclerose méltipla com campath-1h

Info

Publication number: BRPI0716929A2
Authority: BR; Brazil
Prior art keywords: campath; multiple sclerosis; sclerosis treatment; treatment; sclerosis
Prior art date: 2006-09-13

Application number

BRPI0716929-9A2A

Other languages

English (en)

Inventor

Andreas Sachse

David Harris Margolin

Original Assignee

Bayer Schering Pharma Ag

Genzyme Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-13

Filing date

2007-09-11

Publication date

2013-09-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38734000&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0716929(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-09-11 Application filed by Bayer Schering Pharma Ag, Genzyme Corp filed Critical Bayer Schering Pharma Ag

2013-09-17 Publication of BRPI0716929A2 publication Critical patent/BRPI0716929A2/pt

2019-02-05 Publication of BRPI0716929A8 publication Critical patent/BRPI0716929A8/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2893—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

BRPI0716929A 2006-09-13 2007-09-11 tratamento de esclerose múltipla com campath-1h BRPI0716929A8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US84425106P	2006-09-13	2006-09-13
EP06090169		2006-09-14
PCT/EP2007/008084 WO2008031626A1 (en)	2006-09-13	2007-09-11	Treatment of multiple sclerosis (ms) with campath-1h

Publications (2)

Publication Number	Publication Date
BRPI0716929A2 true BRPI0716929A2 (pt)	2013-09-17
BRPI0716929A8 BRPI0716929A8 (pt)	2019-02-05

Family

ID=38734000

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0716929A BRPI0716929A8 (pt)	2006-09-13	2007-09-11	tratamento de esclerose múltipla com campath-1h

Country Status (21)

Country	Link
EP (4)	EP2066352B1 (pt)
JP (6)	JP5872756B2 (pt)
KR (2)	KR101583587B1 (pt)
CN (1)	CN102652832A (pt)
AR (1)	AR062779A1 (pt)
BR (1)	BRPI0716929A8 (pt)
CA (1)	CA2662531A1 (pt)
CY (1)	CY2016019I2 (pt)
DK (1)	DK2066352T3 (pt)
ES (2)	ES2917882T3 (pt)
HR (1)	HRP20160211T1 (pt)
HU (2)	HUE026740T2 (pt)
IL (3)	IL197236A (pt)
LT (1)	LTC2066352I2 (pt)
LU (1)	LU93092I2 (pt)
MX (2)	MX354080B (pt)
PL (2)	PL2066352T3 (pt)
PT (2)	PT3028718T (pt)
RS (1)	RS54658B1 (pt)
SI (1)	SI2066352T1 (pt)
WO (1)	WO2008031626A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2066352B1 (en)	2006-09-13	2015-12-02	Alcafleu Management GmbH & Co. KG	Treatment of multiple sclerosis (ms) with campath-1h
US9498528B2 (en)	2006-09-13	2016-11-22	Genzyme Corporation	Treatment of multiple sclerosis (MS)
MY160126A (en)	2009-05-13	2017-02-28	Genzyme Corp	Anti-human cd52 immunoglobulins
AR095199A1 (es)	2013-03-15	2015-09-30	Genzyme Corp	Anticuerpos anti-cd52
US20200299399A1 (en) *	2017-04-21	2020-09-24	Genzyme Corporation	Treatment of Multiple Sclerosis with Anti-CD52 Antibodies
WO2020123789A1 (en) *	2018-12-12	2020-06-18	Pretzer Aboff Ingrid	Vibrational device and methods for mitigating symptoms of freezing of gait

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5846534A (en)	1988-02-12	1998-12-08	British Technology Group Limited	Antibodies to the antigen campath-1
GB9125768D0 (en) *	1991-12-04	1992-02-05	Hale Geoffrey	Therapeutic method
EP2066352B1 (en)	2006-09-13	2015-12-02	Alcafleu Management GmbH & Co. KG	Treatment of multiple sclerosis (ms) with campath-1h

2007
- 2007-09-11 EP EP07802348.8A patent/EP2066352B1/en active Active
- 2007-09-11 CN CN2012100864372A patent/CN102652832A/zh active Pending
- 2007-09-11 PL PL07802348T patent/PL2066352T3/pl unknown
- 2007-09-11 PL PL15191491.8T patent/PL3028718T3/pl unknown
- 2007-09-11 WO PCT/EP2007/008084 patent/WO2008031626A1/en not_active Ceased
- 2007-09-11 EP EP15191491.8A patent/EP3028718B1/en active Active
- 2007-09-11 MX MX2013009511A patent/MX354080B/es unknown
- 2007-09-11 RS RS20160081A patent/RS54658B1/sr unknown
- 2007-09-11 EP EP11189431A patent/EP2433649A3/en not_active Withdrawn
- 2007-09-11 BR BRPI0716929A patent/BRPI0716929A8/pt active Search and Examination
- 2007-09-11 MX MX2009002660A patent/MX2009002660A/es active IP Right Grant
- 2007-09-11 DK DK07802348.8T patent/DK2066352T3/en active
- 2007-09-11 HR HRP20160211T patent/HRP20160211T1/hr unknown
- 2007-09-11 ES ES15191491T patent/ES2917882T3/es active Active
- 2007-09-11 KR KR1020097005111A patent/KR101583587B1/ko active Active
- 2007-09-11 HU HUE07802348A patent/HUE026740T2/en unknown
- 2007-09-11 KR KR20157007655A patent/KR20150039879A/ko not_active Ceased
- 2007-09-11 SI SI200731746A patent/SI2066352T1/sl unknown
- 2007-09-11 PT PT151914918T patent/PT3028718T/pt unknown
- 2007-09-11 JP JP2009527751A patent/JP5872756B2/ja active Active
- 2007-09-11 ES ES07802348.8T patent/ES2563068T3/es active Active
- 2007-09-11 PT PT78023488T patent/PT2066352E/pt unknown
- 2007-09-11 EP EP11189428A patent/EP2444104A3/en not_active Withdrawn
- 2007-09-11 CA CA002662531A patent/CA2662531A1/en not_active Abandoned
- 2007-09-13 AR ARP070104053A patent/AR062779A1/es not_active Application Discontinuation
2009
- 2009-02-25 IL IL197236A patent/IL197236A/en active IP Right Grant
2013
- 2013-12-02 JP JP2013249139A patent/JP6257287B2/ja active Active
2015
- 2015-08-06 IL IL240394A patent/IL240394B/en active IP Right Grant
2016
- 2016-05-02 JP JP2016092377A patent/JP2016175929A/ja active Pending
- 2016-05-30 LT LTPA2016019C patent/LTC2066352I2/lt unknown
- 2016-05-30 HU HUS1600028C patent/HUS1600028I1/hu unknown
- 2016-05-31 CY CY2016019C patent/CY2016019I2/el unknown
- 2016-05-31 LU LU93092C patent/LU93092I2/de unknown
2017
- 2017-08-01 JP JP2017149006A patent/JP2018024655A/ja active Pending
2018
- 2018-02-04 IL IL257341A patent/IL257341A/en unknown
2019
- 2019-06-19 JP JP2019113260A patent/JP2019167385A/ja active Pending
2021
- 2021-04-14 JP JP2021068079A patent/JP2021107423A/ja active Pending

Also Published As

Publication number	Publication date
LTPA2016019I1 (lt)	2016-06-27
IL240394B (en)	2018-02-28
RU2009113665A (ru)	2010-10-20
JP2010503631A (ja)	2010-02-04
SI2066352T1 (sl)	2016-05-31
EP3028718B1 (en)	2022-03-23
IL197236A (en)	2015-08-31
JP5872756B2 (ja)	2016-03-01
EP2433649A2 (en)	2012-03-28
JP6257287B2 (ja)	2018-01-10
PT3028718T (pt)	2022-06-09
PT2066352E (pt)	2016-03-31
CA2662531A1 (en)	2008-03-20
KR20090063215A (ko)	2009-06-17
AU2007296857A1 (en)	2008-03-20
CN102652832A (zh)	2012-09-05
EP2444104A2 (en)	2012-04-25
EP3028718A1 (en)	2016-06-08
KR20150039879A (ko)	2015-04-13
HK1136773A1 (en)	2010-07-09
JP2019167385A (ja)	2019-10-03
JP2016175929A (ja)	2016-10-06
JP2021107423A (ja)	2021-07-29
MX2009002660A (es)	2009-06-11
PL2066352T3 (pl)	2016-05-31
HRP20160211T1 (hr)	2016-03-25
KR101583587B1 (ko)	2016-01-08
MX354080B (es)	2018-02-12
EP2066352B1 (en)	2015-12-02
HUE026740T2 (en)	2016-07-28
EP2444104A3 (en)	2012-10-24
CY2016019I1 (el)	2016-10-05
RS54658B1 (sr)	2016-08-31
LTC2066352I2 (lt)	2017-09-25
IL257341A (en)	2018-03-29
WO2008031626A1 (en)	2008-03-20
CY2016019I2 (el)	2016-10-05
ES2917882T3 (es)	2022-07-12
JP2014058555A (ja)	2014-04-03
AR062779A1 (es)	2008-12-03
DK2066352T3 (en)	2016-02-29
ES2563068T3 (es)	2016-03-10
EP2066352A1 (en)	2009-06-10
IL197236A0 (en)	2011-08-01
LU93092I2 (de)	2016-08-01
EP2433649A3 (en)	2012-10-31
IL240394A0 (en)	2015-09-24
BRPI0716929A8 (pt)	2019-02-05
JP2018024655A (ja)	2018-02-15
HUS1600028I1 (hu)	2016-07-28
PL3028718T3 (pl)	2022-11-21

Legal Events

Date	Code	Title	Description
2013-12-17	B25A	Requested transfer of rights approved	Owner name: GENZYME CORPORATION (US) , ALCAFLEU MANAGEMENT GMB
2013-12-31	B15G	Petition not considered as such [chapter 15.7 patent gazette]	Free format text: A PETICAO DE NO 20110064524, APRESENTADA EM 20/06/2011, EM VIRTUDE DO DISPOSTO NOS ARTS. 218 OU 219 DA LPI (LEI 9279 / 96) DE 14/05/1996, E CONSIDERADA COMO PETICAO NAO CONHECIDA, UMA VEZ QUE A ALTERACAO SOLICITADA JA FORA CONSUBSTANCIADA NA RPI NO 2241, DE 17/12/2013.
2016-06-14	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2017-04-04	B25E	Requested change of name of applicant rejected	Owner name: GENZYME CORPORATION (US) , ALCAFLEU MANAGEMENT GMB
2018-04-24	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-10-23	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-02-12	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-06-18	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-12-17	B12B	Appeal against refusal [chapter 12.2 patent gazette]

Publication	Publication Date	Title
BRPI0718313A2 (pt)	2013-11-26	Conjunto de cateter
ES2527265T8 (es)	2015-04-20	Consola
CR10841A (es)	2009-06-30	Imidazotriazinas imidazopirimidinas inhibidores de cinasa
BRPI0811931A2 (pt)	2014-11-25	Corpo de múltiplas camadas
PT2051744E (pt)	2014-02-06	Aparelho de esterilização
EP2089308A4 (en)	2014-08-06	DONOR
IL197818A0 (en)	2011-08-01	Multiple sclerosis therapy
HUE037890T2 (hu)	2018-09-28	Sclerosis tuberosa kezelése
EP2081520A4 (en)	2012-08-01	MEDICAL IMPLANTS
DK2035369T3 (da)	2014-10-06	Terapeutiske
GB0624874D0 (en)	2007-01-24	Treatment
PL2205720T3 (pl)	2017-06-30	Kompozycja do leczenia stwardnienia rozsianego
FR2908035B1 (fr)	2009-05-01	Implant interepineux
EP2010561A4 (en)	2010-03-24	ANTIMICROBIAL PEPTIDES
DK2173831T3 (da)	2012-09-17	Brøndbehandling
GB0702931D0 (en)	2007-03-28	Skin application
LTPA2016019I1 (lt)	2016-06-27	Išsėtinės sklerozės (MS) gydymas kampatu-1H
GB0600692D0 (en)	2006-02-22	Well treatment
EP2214719A4 (en)	2014-10-01	Metallofullerene-DYE
BRPI0712951A2 (pt)	2013-10-29	Unidade de aplicação
PT2062053E (pt)	2013-02-11	Métodos de imunoensaio melhorados
GB0607952D0 (en)	2006-05-31	Novel treatment
GB0604460D0 (en)	2006-04-12	Treatment
FI20060917A7 (fi)	2008-04-18	Tahtikone
GB0614058D0 (en)	2006-08-23	Treatment for multiple sclerosis